Age disparities in stage‐specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK ‐2 population‐based study

Author:

Pilleron Sophie1ORCID,Charvat Hadrien1,Araghi Marzieh1,Arnold Melina1ORCID,Fidler‐Benaoudia Miranda M.1,Bardot Aude1,Guren Marianne Grønlie2ORCID,Tervonen Hanna3,Little Alana3,O'Connell Dianne L.3,Gavin Anna4,De Prithwish5,Aagard Thomsen Linda6,Møller Bjørn7,Jackson Christopher8,Bucher Oliver9,Walsh Paul M.10,Vernon Sally11,Bray Freddie1ORCID,Soerjomataram Isabelle1

Affiliation:

1. Section of Cancer Surveillance International Agency for Research on Cancer Lyon France

2. Department of Oncology and K.G. Jebsen Colorectal Cancer Research Centre Oslo University Hospital Oslo Norway

3. Cancer Research Division Cancer Council NSW Sydney Australia

4. Northern Ireland Cancer Registry Queen's University Belfast Belfast Northern Ireland UK

5. Surveillance and Cancer Registry Ontario Health (Cancer Care Ontario) Toronto Ontario Canada

6. The Danish Cancer Society (Kræftens Bekæmpelse) Copenhagen Denmark

7. Cancer Registry of Norway Department of Registration Oslo Norway

8. Cancer Society of New Zealand Wellington New Zealand

9. Department of Epidemiology and Cancer Registry CancerCare Manitoba Winnipeg Manitoba Canada

10. National Cancer registry Ireland Cork Ireland

11. Public Health England London England UK

Funder

Cancer Council Victoria

Cancer Institute NSW

Cancer Research UK

FP7 People: Marie-Curie Actions

Kræftens Bekæmpelse

Kreftforeningen

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. FerlayJ ErvikM LamF et al.Global Cancer Observatoryhttps://www.gco.iarc.fr/Accessed August 17 2020.

2. Colon and rectal cancer survival in seven high‐income countries 2010–2014: variation by age and stage at diagnosis (the ICBP SURVMARK‐2 project);Araghi M;Gut,2020

3. The cancer survival gap between elderly and middle-aged patients in Europe is widening

4. Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: A study of five common cancers

5. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3